Literature DB >> 24074383

Prodrug micelle-based nanomedicine for cancer treatment.

Yu Mi1, Jing Zhao, Si-Shen Feng.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24074383     DOI： 10.2217/nnm.13.121

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN： 1743-5889            Impact factor:   5.307


× No keyword cloud information.
  2 in total

1.  Tunable self-assembly of Irinotecan-fatty acid prodrugs with increased cytotoxicity to cancer cells.

Authors:  Chunqiu Zhang; Shubin Jin; Xiangdong Xue; Tingbin Zhang; Yonggang Jiang; Paul C Wang; Xing-Jie Liang
Journal:  J Mater Chem B       Date:  2016-04-14       Impact factor: 6.331

2.  Combination delivery of Adjudin and Doxorubicin via integrating drug conjugation and nanocarrier approaches for the treatment of drug-resistant cancer cells.

Authors:  Xu Li; Cuixia Gao; Yupei Wu; C-Yan Cheng; Weiliang Xia; Zhiping Zhang
Journal:  J Mater Chem B       Date:  2015-01-02       Impact factor: 6.331
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.